New inhaler propellant passes first test in healthy volunteers
NCT ID NCT06433908
First seen Jan 12, 2026 · Last updated May 01, 2026 · Updated 16 times
Summary
This study tested a new version of the propellant used in salbutamol inhalers (a common asthma rescue medication) to see if it delivers the drug similarly to the current propellant. Sixty healthy adults aged 18 to 55 received single doses of salbutamol via both inhaler types. The goal was to compare how much drug gets into the blood and how fast, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.